Putamen News and Research

RSS

Experimental treatment shown to reverse the loss of nerve fibres in Parkinson's Disease

Analysis of the brain of a patient suffering from Parkinson's Disease has shown that the experimental treatment he received caused regrowth of the nerve fibres that are lost in this disease. The findings are reported in the July issue of Nature Medicine.

6 Jul 2005

Withdrawn experimental drug found to reverse Parkinson's brain damage

Neuroscientists at Frenchay hospital in Bristol have discovered that an experimental drug for Parkinson's disease has been shown to trigger new nerve growth in the brain, the first time any treatment has been found to reverse the brain damage caused by the condition.

5 Jul 2005

Experimental treatment regrows nerve fibres in patient suffering Parkinson's disease

Analysis of the brain of a patient suffering from Parkinson’s Disease has shown that the experimental treatment he received caused regrowth of the nerve fibres that are lost in this disease. The findings are reported in the July issue of Nature Medicine.

30 Jun 2005

Scientists can now explain why the brain prefers one brand of soft drink to another

A study involving 67 people showed no preference for either Coca-Cola® (Coke®) or Pepsi® when the drinks were administered anonymously, according to results published in the Oct. 14 issue of the journal Neuron.

13 Oct 2004

Discovery of dopamine terminal injury in brains of people with HIV dementia

Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have discovered a key mechanism in the brains of people with human immunodeficiency virus (HIV) dementia.

20 Sep 2004

Putamen News and Research

Experimental treatment shown to reverse the loss of nerve fibres in Parkinson's Disease

Withdrawn experimental drug found to reverse Parkinson's brain damage

Experimental treatment regrows nerve fibres in patient suffering Parkinson's disease

Scientists can now explain why the brain prefers one brand of soft drink to another

Discovery of dopamine terminal injury in brains of people with HIV dementia

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest News